Evidence of two mechanisms of prostaglandin release in an in vitro model of muscle damage. Possible therapeutic implications
Authors:
- Valerie A. CwikVCValerie A. Cwik
- Michael H. BrookeMBMichael H. Brooke
- 1 September 1994
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 4 (5-6) , 483-488
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The oxidant stress hypothesis in Parkinson's disease: Evidence supporting itAnnals of Neurology, 1992
- Protection against ischemic hippocampal CAI damage in the rat with a new non-NMDA antagonist, NBQXActa Neurologica Scandinavica, 1992
- Protection by N- receptor antagonists against impairment of working memory in rats following transient cerebral ischemiaNeuroscience Letters, 1992
- The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal strokeBrain Research, 1992
- An introduction to the free radical hypothesis in Parkinson's diseaseAnnals of Neurology, 1992
- Postischemic Blockade of AMPA but Not NMDA Receptors Mitigates Neuronal Damage in the Rat Brain following Transient Severe Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1992
- Results of antagonists in perinatal cerebral asphyxia therapyPediatric Neurology, 1990
- Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the ratBrain Research, 1990
- N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia?Annals of Neurology, 1989
- Study of long‐term anticholinesterase therapyNeurology, 1973